{"owner": "ArrayExpress Uploader", "pop_total": 0, "species": "human", "factors": [{"GSM1229922": {"COMPOUND": "ALK inhibitor CEP-14083"}}, {"GSM1229922": {"COMPOUND": "ALK inhibitor CEP-14083"}}, {"GSM1229922": {"COMPOUND": "ALK inhibitor CEP-14083"}}, {"GSM1229919": {"COMPOUND": "control"}}, {"GSM1229919": {"COMPOUND": "control"}}, {"GSM1229919": {"COMPOUND": "control"}}], "id": 2243, "ownerprofile_id": "arrayexpress_sid", "platform": 4, "summary_wrapped": "In this study we compared the effects of ALK inhibitor on the gene expression, activation of cell signaling pathways, and functional...", "geo_gse_id": "E-GEOD-50803", "owner_profile": "/profile/8773/arrayexpressuploader", "factor_count": 1, "sample_count": 6, "tags": ["anaplastic large cell lymphoma", "cell", "genome", "line", "lymphoma"], "lastmodified": "Dec.12, 2014", "is_default": false, "geo_gds_id": "", "slug": "expression-of-sudhl-1-cell-line-treated-by-alk-inh", "geo_id_plat": "E-GEOD-50803_A-AFFY-44", "name": "Expression of SUDHL-1 cell line treated by ALK inhibitors", "created": "Jul.11, 2014", "summary": "In this study we compared the effects of ALK inhibitor on the gene expression, activation of cell signaling pathways, and functional properties of cells derived from a patient with Anaplastic Large Cell Lymphoma. we used microarrays to map the genome-wide gene expression patterns in ALK+TCL cells in response to ALK inhibition. The ALK+TCL Sudhl-1 cell line was treated in triplicates with the ALK inhibitor, CEP-14083, or the compound's solvent for 6 h. The isolated RNA was reverse-transcribed, biotin-labeled, and hybridized to the U133 Plus 2.0 array chips (Affymetrix). Microarray data were normalized using the MAS5 algorithm and analyzed using Partek GS (Partek).", "source": "http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-50803", "sample_source": "http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-50803/samples/"}